Where does Mello Biotechnology, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mello Biotechnology, Inc. ranks #48,662 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Mello Biotechnology, Inc. hold?

Mello Biotechnology, Inc. holds 5 US utility patents granted between 2017 and 2019, spanning 3 technology areas.

What is Mello Biotechnology, Inc.'s Innovation Score?

Mello Biotechnology, Inc. has an Innovation Score of 23.1 out of 100 (11th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Mello Biotechnology, Inc.'s patent grant rate increasing or decreasing?

Mello Biotechnology, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Mello Biotechnology, Inc.'s patents?

Mello Biotechnology, Inc.'s patents average 18.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Mello Biotechnology, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Mello Biotechnology, Inc.

Q: What technology areas does Mello Biotechnology, Inc. focus on?

Mello Biotechnology, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 5 patents. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2017–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mello ranks #48,662 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#48,662
of 49,997 US assignees by volume: 11th percentile
by Innovation Score (23.1/100): 18.0
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R48662 · US Corporation #48,662 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,662/49,997
PHOTO-FINISH Medskin Solutions…
CPC-NARROW C12N · 3 areas
INNOV-THIN 23.1/100
CLAIMS-RICH 18.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Medskin Solutions DR. Suwelack AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Mello Biotechnology · this assignee

23
3D Lighting… · lowest

7

What this shows Mello's Innovation Score is 23.1/100 (11th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Mello's grants concentrate

Mello Biotechnology, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2018. By volume, Mello sits between Medskin Solutions DR. Suwelack AG and Memometal Technologies.

Medskin Solutions…

5
MEG Group

5
Meld Manufacturing

5
Meljac

5
Memblaze Technolo…

5
Memc Singapore Pt…

5
Memgen

5
Memometal

5
Mello Biotechnolo… ◀

5

What this shows Mello holds 5 patents at rank #48,591, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mello

By rank, the assignees closest to #48,591 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Mello's primary technology class.

Mello's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

23 11th percentile higher than 11% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Mello Biotechnology, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	60.0%
2018	1	20.0%
2019	1	20.0%

Which technologies does Mello Biotechnology, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

Top 3 of 3 technology areas

Where it ranks

Overall rank by patents

#48,662

of 49,997 tracked assignees

Innovation Score

23.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Mello Biotechnology, Inc.'s patent record in context - here's where to go next.

Mello Biotechnology, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #48,662 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mello Biotechnology, Inc. against Medskin Solutions DR. Suwelack AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 23.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.